OBJECTIVE: Innate mucosal factors are associated with protection in HIV-exposed seronegative (HESN) individuals, but studies of MSM have been very limited. We performed proteomic analysis of saliva from a cohort of HESN MSM who have regular unprotected oral receptive intercourse with their HIV-infected partner. METHODS: Saliva samples from HESN (n = 25) and non-exposed male controls (n = 22) were analyzed by 2D-LC mass spectrometry. An overexpressed innate protein factor was further characterized by immunoblot, and compared with CC-chemokine expression, HIV-neutralizing activity, clinical factors, and sexual behavior. RESULTS: Of 337 total proteins, seven were identified as differentially abundant in the HESN group. The five overabundant proteins (Basic salivary proline-rich proteins (bPRP) 2 and 3, Histatin-3, Lysozyme C, and SLPI) have known antimicrobial activity. bPRP2 showed the highest overabundance (>six-fold) in HESN individuals compared with controls (P = 0.009), including multiple isoforms. Salivary bPRP2 correlated with CC-chemokine levels in HESN individuals including RANTES (P = 0.02), MIP-1-alpha (P = 0.01), MIP-1-beta (P = 0.0002), MCP-1 (P = 0.005) and Eotaxin (P = 0.003) but not with frequency of HIV neutralizing activity, oral sexual practices, or viral load of the sexual partner. CONCLUSION: This study identifies salivary bPRP2 as a novel soluble factor elevated in the oral compartment of HIV-exposed MSM.
OBJECTIVE: Innate mucosal factors are associated with protection in HIV-exposed seronegative (HESN) individuals, but studies of MSM have been very limited. We performed proteomic analysis of saliva from a cohort of HESN MSM who have regular unprotected oral receptive intercourse with their HIV-infected partner. METHODS: Saliva samples from HESN (n = 25) and non-exposed male controls (n = 22) were analyzed by 2D-LC mass spectrometry. An overexpressed innate protein factor was further characterized by immunoblot, and compared with CC-chemokine expression, HIV-neutralizing activity, clinical factors, and sexual behavior. RESULTS: Of 337 total proteins, seven were identified as differentially abundant in the HESN group. The five overabundant proteins (Basic salivary proline-rich proteins (bPRP) 2 and 3, Histatin-3, Lysozyme C, and SLPI) have known antimicrobial activity. bPRP2 showed the highest overabundance (>six-fold) in HESN individuals compared with controls (P = 0.009), including multiple isoforms. Salivary bPRP2 correlated with CC-chemokine levels in HESN individuals including RANTES (P = 0.02), MIP-1-alpha (P = 0.01), MIP-1-beta (P = 0.0002), MCP-1 (P = 0.005) and Eotaxin (P = 0.003) but not with frequency of HIV neutralizing activity, oral sexual practices, or viral load of the sexual partner. CONCLUSION: This study identifies salivary bPRP2 as a novel soluble factor elevated in the oral compartment of HIV-exposed MSM.
Authors: Rada Ellegård; Elisa Crisci; Adam Burgener; Christopher Sjöwall; Kenzie Birse; Garrett Westmacott; Jorma Hinkula; Jeffrey D Lifson; Marie Larsson Journal: J Immunol Date: 2014-09-24 Impact factor: 5.422
Authors: Kelly B Arnold; Adam Burgener; Kenzie Birse; Laura Romas; Laura J Dunphy; Kamnoosh Shahabi; Max Abou; Garrett R Westmacott; Stuart McCorrister; Jessie Kwatampora; Billy Nyanga; Joshua Kimani; Lindi Masson; Lenine J Liebenberg; Salim S Abdool Karim; Jo-Ann S Passmore; Douglas A Lauffenburger; Rupert Kaul; Lyle R McKinnon Journal: Mucosal Immunol Date: 2015-06-24 Impact factor: 7.313
Authors: S A Vishwanathan; A Burgener; S E Bosinger; G K Tharp; P C Guenthner; N B Patel; K Birse; D L Hanson; G R Westmacott; T R Henning; J Radzio; J G Garcia-Lerma; T B Ball; J M McNicholl; E N Kersh Journal: J Virol Date: 2015-06-24 Impact factor: 5.103
Authors: J L Prodger; T Hirbod; G Kigozi; F Nalugoda; S J Reynolds; R Galiwango; K Shahabi; D Serwadda; M J Wawer; R H Gray; R Kaul Journal: Mucosal Immunol Date: 2013-10-23 Impact factor: 7.313
Authors: Cecilia Svanberg; Rada Ellegård; Elisa Crisci; Mohammad Khalid; Ninnie Borendal Wodlin; Maria Svenvik; Sofia Nyström; Kenzie Birse; Adam Burgener; Esaki M Shankar; Marie Larsson Journal: Front Immunol Date: 2021-05-20 Impact factor: 7.561
Authors: Kenzie M Birse; Adam Burgener; Garrett R Westmacott; Stuart McCorrister; Richard M Novak; T Blake Ball Journal: PLoS One Date: 2013-11-14 Impact factor: 3.240
Authors: Laura M Romas; Klara Hasselrot; Lindsay G Aboud; Kenzie D Birse; T Blake Ball; Kristina Broliden; Adam D Burgener Journal: PLoS One Date: 2014-06-30 Impact factor: 3.240